Literature DB >> 10610767

Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation.

N Dias1, S Dheur, P E Nielsen, S Gryaznov, A Van Aerschot, P Herdewijn, C Hélène, T E Saison-Behmoaras.   

Abstract

We have previously described the rational design of mutation-selective antisense oligonucleotides targeted to codon 12 of oncogenic Ha-ras mRNA. In order to further improve the biological efficacy of these unmodified oligonucleotides, we have studied three different classes of modifications: peptide nucleic acid backbone (PNA), sugar modification (2'-O-methyl) and phosphoramidate linkage (PN). We show that PNA is unique among the investigated steric blocking agents in its ability to specifically inhibit the translation of Ha-ras mRNA in vitro. The PNA-RNA hybrid (Tm=86 degrees C), which is not dissociated by cellular proteins and resists phenol extraction and urea denaturing conditions, specifically blocks the translation of mutated Ha-ras mRNA. A PNA tridecamer which forms with wild-type Ha-ras mRNA a duplex with a central mismatch had little effect on mRNA translation. Codon 12 is located close to the translation initiation site and hybridization of the PNA at this position may interfere with the assembly of the translation initiation complex. To test whether polypeptide chain elongation can also be blocked, we have targeted PNA tridecamers to codons in the 74, 128 and 149 regions. These PNAs form equally stable duplexes as that formed by the PNA targeted to the codon 12 region (ten G.C base-pairs out of 13). We show that PNA-RNA duplexes block the progression of the 80 S ribosome. Therefore, it is possible to arrest translation with concomitant production of a truncated protein by using duplex-forming PNA oligonucleotides targeted to a G+C-rich sequences. Our data demonstrate for the first time that a non-covalent duplex can arrest the translation machinery and polypeptide chain elongation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10610767     DOI: 10.1006/jmbi.1999.3277

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

Review 1.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

Review 2.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

3.  Destabilization of tRNA3(Lys) from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog.

Authors:  N Kaushik; T T Talele; R Monel; P Palumbo; V N Pandey
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

4.  Improved hybridisation potential of oligonucleotides comprising O-methylated anhydrohexitol nucleoside congeners.

Authors:  A Van Aerschot; M Meldgaard; G Schepers; F Volders; J Rozenski; R Busson; P Herdewijn
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

5.  Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids.

Authors:  Valentina Rapozzi; Brigitte E A Burm; Susanna Cogoi; Gijs A van der Marel; Jacques H van Boom; Franco Quadrifoglio; Luigi E Xodo
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

6.  Steric inhibition of human immunodeficiency virus type-1 Tat-dependent trans-activation in vitro and in cells by oligonucleotides containing 2'-O-methyl G-clamp ribonucleoside analogues.

Authors:  Stephen C Holmes; Andrey A Arzumanov; Michael J Gait
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

7.  Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.

Authors:  Keith T Gagnon; Hannah M Pendergraff; Glen F Deleavey; Eric E Swayze; Pierre Potier; John Randolph; Eric B Roesch; Jyoti Chattopadhyaya; Masad J Damha; C Frank Bennett; Christophe Montaillier; Marc Lemaitre; David R Corey
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

8.  In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides.

Authors:  Kees Fluiter; Anneloor L M A ten Asbroek; Marit B de Wissel; Marja E Jakobs; Margit Wissenbach; Håkan Olsson; Otto Olsen; Henrik Oerum; Frank Baas
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

9.  Using peptide nucleic acids as gene-expression modifiers to reduce beta-amyloid levels.

Authors:  Beth M McMahon; Jennifer Stewart; Abdul Fauq; Steven Younkin; Linda Younkin; Elliott Richelson
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

10.  Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.

Authors:  Moizza Mansoor; Alirio J Melendez
Journal:  Gene Regul Syst Bio       Date:  2008-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.